
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
Keywords: VEGF; vascular endothelial growth factor; FGF-2; fibroblast grow factor 2; PDGF-BB; platelet-derived growth factor-BB; VEGFR2; VEGF receptor 2; FGFR1; FGF receptor 1; PDGFRβ; PDGF receptor β; TKI; tyrosine kinase inhibitor; DMSO; dimethylsulfoxide; BSA;